AR069648A1 - Composiciones topicas que comprenden aminoacidos no proteinogenicos y metodos de tratamiento de la piel - Google Patents

Composiciones topicas que comprenden aminoacidos no proteinogenicos y metodos de tratamiento de la piel

Info

Publication number
AR069648A1
AR069648A1 ARP080105377A ARP080105377A AR069648A1 AR 069648 A1 AR069648 A1 AR 069648A1 AR P080105377 A ARP080105377 A AR P080105377A AR P080105377 A ARP080105377 A AR P080105377A AR 069648 A1 AR069648 A1 AR 069648A1
Authority
AR
Argentina
Prior art keywords
alkyl
proteinogenic amino
nrn
amino acid
ring
Prior art date
Application number
ARP080105377A
Other languages
English (en)
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of AR069648A1 publication Critical patent/AR069648A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se divulgan composiciones cosméticas que comprenden aminoácidos no proteinogénicos no naturales y métodos de uso de tales composiciones para impartir beneficios antienvejecimiento en la piel. Se cree que los aminoácidos no proteinogénicos no naturales tienen una actividad modulatoria contra uno o más vías bioquímicas implicadas en el envejecimiento de la piel, y en particular, que son potenciadores de la LOXL-1, (lisil oxidasa tipo 1). Reivindicacion 1: Una composicion cosmética para el tratamiento de una condicion de la piel asociada con la pérdida de fibra elastina que comprende una cantidad efectiva de un aminoácido no proteinogénico potenciador de la LOXL-1 o derivado del mismo en un vehículo aceptable en términos cosméticos. Reivindicacion 2: La composicion de la reivindicacion 1 donde dicho aminoácido no proteinogénico es un alfa-aminoácido o un beta-aminoácido que comprende un grupo heterocíclico de conformidad con la formula 1, donde n es 0 o 1; Z es seleccionada entre el grupo conformado por un enlace, oxígeno, azufre, NRN, alquilo C1-6, alquenilo, alquinilo, arilo, carbonilo, carboxilo, carbamilo, donde RN es hidrogeno, alquilo, alquenilo, alquinilo o arilo C1-6; Y es seleccionado entre C, CH, N, o NRN, donde RN es como se definio anteriormente; y Q es un anillo o sistema de anillos heterocíclicos de 3 a 10 miembros que incluye Y y que comprende uno o más heteroátomos en el anillo o sistema de anillos, seleccionado entre oxígeno, nitrogeno y azufre y que es opcionalmente sustituido con uno o más grupos R1 unidos al sistema de anillos donde R1 es independientemente en cada caso seleccionado entre hidrogeno, halogeno; -OH; -NH2, -NRNRN; -SH; -CN; oxo; -CHO; -CO2H; -O-(C=O)-H; -O-(C=O)-alquilo C1-10; -O-(C=O)-Ar; -(C=O)-O-alquilo C1-10; -(C=O)-O-Ar; -(C=O)-NRNRN; -O-alquilo C1-10; -O-Ar; -S-alquilo C1-10; -S-Ar; -Ar; alquilo C1-10; -NRN-CHO; -NRN-(C=O)-alquilo C1-10; alquilo C1-10-O-alquilo C1-10; perfluoroalquilo; epoxi; azida; tiocianato; -SO2-RN; y nitro; donde RN es como se definio anteriormente y en el caso donde el sustituyente comprende dos grupos RN, estos pueden conjuntamente formar un anillo; con la condicion de que el compuesto de la formula 1 no sea L-histidina o L-triptofano.
ARP080105377A 2007-12-19 2008-12-11 Composiciones topicas que comprenden aminoacidos no proteinogenicos y metodos de tratamiento de la piel AR069648A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1484607P 2007-12-19 2007-12-19

Publications (1)

Publication Number Publication Date
AR069648A1 true AR069648A1 (es) 2010-02-10

Family

ID=40795847

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105377A AR069648A1 (es) 2007-12-19 2008-12-11 Composiciones topicas que comprenden aminoacidos no proteinogenicos y metodos de tratamiento de la piel

Country Status (12)

Country Link
US (2) US8168212B2 (es)
EP (1) EP2229138B1 (es)
JP (1) JP5554720B2 (es)
CN (1) CN101903010B (es)
AR (1) AR069648A1 (es)
BR (1) BRPI0819931B1 (es)
CA (1) CA2707768C (es)
ES (1) ES2756350T3 (es)
HK (1) HK1145982A1 (es)
PL (1) PL2229138T3 (es)
TW (1) TWI453037B (es)
WO (1) WO2009079126A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110159125A1 (en) * 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
GB201021457D0 (en) * 2010-12-17 2011-02-02 Univ Manchester Anti-ageing agents
CN102731446B (zh) * 2011-04-12 2016-04-06 新疆大学 3-(噻唑-2-基)-L-丙氨酸过渡金属配合物催化氧化四氢呋喃制备γ-丁内酯和丁二酸的方法
US9044408B2 (en) * 2011-10-31 2015-06-02 Avon Products, Inc. Cosmetic use of N-heteroarylbisamide analogs and related compounds
WO2013167012A2 (zh) * 2013-06-27 2013-11-14 凯莱英医药集团(天津)股份有限公司 L-杂环氨基酸的合成方法及具有其的药物组合物
US11306214B2 (en) 2016-05-09 2022-04-19 North Carolina State University Fractal-like polymeric particles and their use in diverse applications
EP3983382A4 (en) * 2019-06-11 2022-09-07 Fortephest Ltd. NOVEL NON-CODING HETEROCYCLIC AMINO ACIDS (NCHAA) AND THEIR USE AS HERBICIDES
FR3127405A1 (fr) 2021-09-30 2023-03-31 L'oreal ROUGES à LèVRES COMPORTANT UNE HUILE NATURELLE, UNE CIRE D’ALCOOL GRAS ET DES PARTICULES DE CHARGE
EP4363060A1 (en) 2021-06-30 2024-05-08 L'oreal Lipsticks having natural oil, fatty alcohol wax and filler particles

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5123593B2 (es) * 1972-08-25 1976-07-17
WO1990006102A1 (en) * 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
CA2004846A1 (en) * 1988-12-19 1990-06-19 Yutaka Koike N-substituted acylamino acid compounds, process for their production and their use
US5122514A (en) 1990-04-23 1992-06-16 Abbott Laboratories Psoriasis treatment
US5275950A (en) 1990-05-11 1994-01-04 Abbott Laboratories Process for the preparation of a renin inhibiting compound
US5330996A (en) * 1991-10-29 1994-07-19 G. D. Searle & Co. Amino acyl amino propargyl diol compounds for treatment of hypertension
US5851994A (en) * 1994-04-28 1998-12-22 La Jolla Cancer Research Foundation Compositions that inhibit wound contraction and methods of using same
CZ418198A3 (cs) * 1996-06-27 1999-06-16 The Procter & Gamble Company Kosmetické přípravky pro lokální aplikaci na pokožku
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
EP1069118B1 (en) * 1998-03-02 2004-09-22 Shionogi & Co., Ltd. Process for producing 4-thiazolylmethyl derivative
US6455751B1 (en) * 1999-03-03 2002-09-24 The Regents Of The University Of California Oxidizer gels for detoxification of chemical and biological agents
JP2003081950A (ja) * 2001-09-12 2003-03-19 Tosoh Corp L−チアゾリルアラニンの製造方法
US20040033246A1 (en) 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging
US20050048016A1 (en) * 2003-07-02 2005-03-03 L'oreal Composition containing a silicone elastomer and a block silicone copolymer
US20050074473A1 (en) * 2003-10-07 2005-04-07 Cabot Corporation Soft-focus cosmetic composition comprising fumed alumina
US7255856B2 (en) 2004-01-23 2007-08-14 Massachusetts Eye & Ear Infirmary Lysyl oxidase-like 1 (LOXL1) and elastogenesis
JP4527451B2 (ja) * 2004-06-14 2010-08-18 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維の形成を刺激するための、loxl(リシルオキシダーゼ類似)アイソフォームの合成及び活性の刺激
WO2006060548A2 (en) * 2004-12-02 2006-06-08 Ebersytes, Llc Novel dermatological composition using bio-activating organocatalysts
PL2623113T3 (pl) * 2005-11-09 2018-05-30 Onyx Therapeutics, Inc. Związek do hamowania enzymu
FR2894824B1 (fr) * 2005-12-20 2008-03-14 Jean Noel Thorel Utilisation de tryptophane et/ou de 5-hydroxytryptophane,ou d'un extrait vegetal en contenant,comme agent cosmetique
US8603505B2 (en) * 2006-12-21 2013-12-10 Avon Products, Inc. Cosmetic composition containing novel fractal particle based gels having improved optical properties
US9345649B2 (en) * 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels

Also Published As

Publication number Publication date
HK1145982A1 (en) 2011-05-13
WO2009079126A1 (en) 2009-06-25
PL2229138T3 (pl) 2020-03-31
US8168212B2 (en) 2012-05-01
ES2756350T3 (es) 2020-04-27
BRPI0819931B1 (pt) 2017-03-21
EP2229138A1 (en) 2010-09-22
JP2011507864A (ja) 2011-03-10
TWI453037B (zh) 2014-09-21
CN101903010B (zh) 2014-11-26
EP2229138B1 (en) 2019-08-28
US20160038384A1 (en) 2016-02-11
CA2707768C (en) 2016-01-05
JP5554720B2 (ja) 2014-07-23
US20100261769A1 (en) 2010-10-14
CN101903010A (zh) 2010-12-01
TW200930412A (en) 2009-07-16
CA2707768A1 (en) 2009-06-25
EP2229138A4 (en) 2015-01-28
BRPI0819931A2 (pt) 2014-09-30

Similar Documents

Publication Publication Date Title
AR069648A1 (es) Composiciones topicas que comprenden aminoacidos no proteinogenicos y metodos de tratamiento de la piel
PE20120668A1 (es) Un compuesto n,n-dimetil-5-(2-metil-6-((5-metilpirazin-2-il)carbamoil)benzofuran-4-iloxi)pirimidin-carboxamida como activador de glucocinasa
CL2011000159A1 (es) Compuestos derivados de 1,3-oxazin-2-ona, inhibidores de 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes.
BR112021018303A2 (pt) Novos inibidores de pequenas moléculas de fatores de transcrição tead
AR070352A1 (es) Derivado de pirrolopirimidina como inhibidor de la enzima pi3k, un procedimiento de elaboracion del compuesto, una composicion farmaceutica y un agente preventivo o terapeutico en base al compuesto.
ES2572260T3 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas
AR081578A1 (es) Derivados de carbamatos de hexafluoroisopropilo, su preparacion y su aplicacion en terapeutica de patologias mediadas por sustratos metabolizados por la enzima mgl
BRPI0707493B8 (pt) composto inibidor de enzimas e1 ativadoras e composição farmacêutica contendo o referido composto
CR20170070A (es) Composición, método y preparación del ácido biliar sintético
CO6260076A2 (es) Derivados de uracilo o timina para el tratamiento de la hepatitis c
ECSP077309A (es) Compuestos amido y sus usos como farmaceuticos
ECSP088558A (es) Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
ECSP067114A (es) Piperidinas n-sustituidas y su uso como farmacéuticos
UY29457A1 (es) Compuestos novedosos de derivados de aminosulfonilo
ECSP11010798A (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
MX2010008790A (es) Metodo y composicion para reducir el tiempo de secado del cabello.
ECSP109844A (es) Espirociclos como inhibidores de la 11-beta hidroxiesteroide deshidrogenasa de tipo 1
AR068681A1 (es) Inhibidores cristalinos peptidicos de epoxi cetona proteasa y la sintesis de ceto - epoxidos de aminoacidos
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
CO6290658A2 (es) Derivados de azetidina y ciclobutano como inhibidores de jack
AR067663A1 (es) Derivados heterociclicos de etiloxi amidas, composiciones que los comprenden y usos de los mismos en agricultura u horticultura, como agentes antifungicos.
PE20070724A1 (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
GT200600253A (es) Aminopirimidinas como moduladores de quinasas
UY32077A (es) Inhibidores de quinasa tipo polo
CO6290655A2 (es) Inhibidors heterociclicos de estearoil-coa-desaturasa

Legal Events

Date Code Title Description
FG Grant, registration